Patients Stopping Slimming Medications Regain Weight Four Times Faster Than People Using Diet and Exercise

A recent study indicates that individuals who discontinue popular slimming jabs like semaglutide or tirzepatide may regain shed pounds far faster than those who stop traditional diet and exercise plans.

Research printed in a prominent medical journal shows that while overweight individuals often shed a large proportion of their total mass while on the medication, the weight returns at an average rate of nearly a kilo each month upon discontinuation.

"People purchasing these treatments must be informed of the risk of rapid weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.

Such speed of recovery implies a reversion to starting weight within about a year and a half.

Comparing Therapies

The analysis, which reviewed 37 of studies involving thousands of patients, contrasted the outcomes of the injectable medications with older methods.

Scientists note that individuals who lose weight through lifestyle changes alone typically have a more gradual creep back—around 100 grams monthly—after stopping.

The Reason for the Quick Regain

Doctors believe the way of the jabs explains the accelerated weight return.

The injections mimic a body's own chemical called GLP-1, which moderates hunger.

"Long-term administration of the hormone levels several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous hormone, and could lessen sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.

"Withdrawal of this medication leads to appetite is uncontrolled, making binge eating far more likely."

A Chronic Disease?

Health authorities advise the jabs for individuals with obesity-related health risks, alongside prescribed lifestyle changes.

Professionals say that, given the significant potential of relapse, the treatment might need to be life-long.

This view is supported by pharmaceutical companies, who state that the findings "emphasize the long-term nature of excess weight," akin to managing diseases like diabetes.

Patient Experiences

Individuals who have come off the medication report a powerful resurgence of cravings.

"I experienced something that goes on and you become ravenous," said one woman.

This difficulty is compounded if individuals have not developed lasting lifestyle or habit modifications during therapy.

Significant Adoption

Survey data show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.

• Adoption is greater among women compared to men.
• The 40s and 50s demographic shows the greatest usage rates.
• A large proportion obtain the drugs through private prescriptions rather than public health services.

Finally, experts stress that while these medications are powerful tools for weight loss, they are not a standalone fix and long-term success hinges on ongoing behavioural support.